EGFR and breast carcinoma: A number of the associated biomarkers focus on predisposition, as breast cancer has one of the strongest hereditary components associated with germline mutations in BRCA1 and BRCA2. NSCLC shows the largest relative number of predictive biomarkers, consistent with the previous figure showing the importance of EGFR.